Introduction
============

Nemo-like kinase (*NLK*) is a conserved serine/threonine kinase and is involved in a variety of biological responses and is regulated by a variety of different transcription factors ([@b1-or-43-06-1845],[@b2-or-43-06-1845]). Decreased expression of *NLK* was found in various types of human cancers. In human melanoma, decreased expression of *NLK* is associated with poor prognosis and increased vascularity, and metastasis ([@b3-or-43-06-1845]). Decreased expression of *NLK* in human ovarian carcinomas is associated with poor patient survival ([@b4-or-43-06-1845],[@b5-or-43-06-1845]). In addition, *NLK* is significantly downregulated in breast cancer tissues and non-small cell lung cancer (NSCLC) compared with that in corresponding normal tissues ([@b6-or-43-06-1845],[@b7-or-43-06-1845]). *NLK* has also been identified as a tumor-suppressor gene in glioblastoma using an *in vivo* RNAi screen ([@b8-or-43-06-1845]).

Epithelial-mesenchymal transition (EMT) is a biological process, involving the functional transition of polarized epithelial cells into mesenchymal cells, and is involved in cancer metastasis, migration, invasion, and progression ([@b9-or-43-06-1845]--[@b11-or-43-06-1845]). E-cadherin is typically repressed during EMT. Thus, E-cadherin is considered to be a suppressor of migration and invasion of malignant epithelial cancers ([@b12-or-43-06-1845],[@b13-or-43-06-1845]). 14-3-3ζ (also known as *YWHAZ*) is a member of the evolutionally conserved regulatory family that mediates signal transduction by binding to phosphoserine-containing proteins ([@b14-or-43-06-1845]). 14-3-3ζ was found to be responsible for silencing of E-cadherin during EMT ([@b15-or-43-06-1845]).

In the present study, overexpression of *NLK* was found to inhibit the growth and migration of the NSCLC A549 cell line. Moreover, *NLK* interacts with 14-3-3ζ and prevents its dimerization. In addition, *NLK* overexpression was able to restore the expression of E-cadherin inhibited by 14-3-3ζ but not with the fused dimer of 14-3-3ζ. The results from the present study demonstrate that *NLK* is a negative regulator of 14-3-3ζ and plays a tumor-suppressive role by inhibiting the migration of cancer cells.

Materials and methods
=====================

### Cell culture

The human A549, H358, H322, H23, H1437, H1650, Calu-3 and H441 lung cancer epithelial cell lines and human 293T cells were obtained from the Chinese Academy of Sciences cell bank, and were cultured in DMEM (cat no. 10-013-CV; Corning, Inc.) containing 10% FBS (cat no. 35-010-CV; Corning, Inc.), 100 U/ml penicillin and 100 mg/ml streptomycin at 37°C in a 95% humidified incubator with 5% CO~2~.

### Antibodies

Rabbit antibodies to 14-3-3ζ (cat. no. ab155037; dilution 1:1,000) and β-actin (cat. no. ab227387; dilution 1:2,000) were obtained from Abcam. Rabbit antibodies to *NLK* (cat. no. 94350; dilution 1:500), E-cadherin (cat. no. 3195; dilution 1:500) and HA tag (cat. no. 3724; dilution 1:2,000) were purchased from Cell Signaling Technology, Inc. Mouse antibodies to FLAG-M2 tag (cat. no. F1804; dilution 1:2,000), FLAG-M2 affinity gel (cat. no. A2220) and HA affinity gel (cat. no. A2095) were purchased from Sigma-Aldrich (Merck KGaA). Horseradish peroxidase (HRP)-linked anti-mouse IgG (cat. no. 7076; dilution 1:5,000) and anti-rabbit IgG (cat. no. 7074; dilution 1:5,000) were purchased from Cell Signaling Technology, Inc. HRP-linked light chain specific goat anti-mouse IgG (cat. no. 115-005-174) and mouse anti-rabbit IgG (cat. no. 211-002-171) for immunoprecipitation (IP) were purchased from Jackson ImmunoResearch Laboratories, Inc.

### Lentivirus packaging and transduction

The lentivirus pCDH vector containing *NLK*, C-terminal FLAG tagged *NLK*, 14-3-3ζ, C-terminal FLAG/HA tagged 14-3-3ζ, 14-3-3ζ-Fusion \[by a 10-amino acid Glycine (Gly)-rich linker\] and FLAG tagged 14-3-3ζ-Fusion were purchased from Genesent Biological Technology Co., Ltd. To prepare the lentivirus, 293T cells were transfected with the aforementioned lentiviral vectors and packaging plasmids using Lipofectamine^®^ 3000 (Thermo Fisher Scientific, Inc.) according to the manufacturer\'s instructions. Virus-containing medium was collected 48 h after transfection and filtered through 0.45 µM low protein-binding filters (Nalgene; Thermo Fisher Scientific, Inc.). For transduction, cells were infected with lentiviral vectors and selected with puromycin. Subsequently, the expression levels of the target genes were detected using western blot analysis.

### Colony formation assay

For colony formation, A549 cells were seeded in 6-well plates at 500 cells per well, and cultured for 2 weeks. When clones were visible, the colonies were fixed with 4% paraformaldehyde for 30 min and stained with 0.1% crystal violet (Sigma-Aldrich; Merck KGaA) for 5 min. Subsequently images of the cells were obtained and the number of cells were counted under an Olympus BX51 fluorescence microscope (magnification ×100; Olympus Corp.).

### Wound healing assay

Total 5×10^5^ A549 cells infected with different lentivirus were cultured using 6-well plates. After cells had grown to produce a 90% confluent monolayer, a pipette tip (200 µl) was used to create a wound. The cells were washed twice with PBS to remove non-adherent cells and cultured in serum-free medium for 18 or 24 h. Subsequently, the images of wound healing were obtained an Olympus BX51 fluorescence microscope (magnification ×100; Olympus Corp.) and the migration rate was calculated. The migration rate was calculated using the following formula: Migration rate=(Area of original wound - Area of actual wound)/Area of original wound ×100%.

### Sphere formation assay

Monolayer cultured A549 cells (1,000 cells per well) infected with different lentivirus were suspended in 24-well ultra-low attachment plates (Corning, Inc.) with serum-free DMEM/F12 containing 20 ng/ml of epidermal growth factor (Thermo Fisher Scientific, Inc.), 20 ng/ml of basic fibroblast growth factor (Sigma-Aldrich; Merck KGaA) and 2% B27 supplement (Thermo Fisher Scientific, Inc.). After 7 days of incubation, images of the spheres were obtained under a phase-contrast Olympus BX51 microscope (magnification ×100; Olympus Corp.).

### IP and liquid chromatography-mass spectrometry (LC-MS)/MS analysis

For the IP assay, cells were harvested and lysed with RIPA buffer \[50 mM Tris-HCI (pH7.4), 150 mM NaCl, 1.0% NP-40, and 0.25% sodium deoxycholate\] with protease inhibitor and phosphatase inhibitor cocktail (Roche Diagnostics, GmbH). Following brief sonication, the lysates were centrifuged at 15,000 × g for 15 min at 4°C and the supernatants were subsequently incubated with the indicated primary antibodies together with protein A/G-sepharose beads (Santa Cruz Biotechnology, Inc.) or direct with FLAG-M2 affinity gel at 4°C for 2 h. The beads were washed three times before heating or adding FLAG peptides (Sigma-Aldrich; Merck KGaA). Isolated protein, including *NLK*-FLAG and its associated proteins were forwarded to Taiyuan Rosetta Stone Biotech Co., Ltd. for LC-MS/MS analysis. The mass of the peptides was identified using LTQ-XL mass spectrometer (Thermo Fisher Scientific, Inc.).

### SDS-PAGE and western blot analysis

Total proteins were lysed with RIPA lysis buffer (cat. no. 9806; Cell Signaling Technology, Inc.). For denaturing conditions, the cell lysates were mixed with 5X SDS denaturing sample buffer (cat. no. 39000; Thermo Fisher Scientific, Inc.), and incubated at 95°C for 5 min. For non-denaturing conditions, the cell lysates were mixed with 2X SDS non-denaturing sample buffer (cat. no. LC2673; Thermo Fisher Scientific, Inc.) without 2-mercaptoethanol and incubated at room temperature for 60 min. The protein was separated using 12% SDS-PAGE or NativePAGE™ (Thermo Fisher Scientific, Inc.), and subsequently transferred onto a PVDF membrane (EMD Millipore; Merck KGaA). The PVDF membranes were blocked in 5% skimmed milk for 1 h at room temperature, and incubated with aforementioned primary antibodies overnight at 4°C. Following which, the membranes were washed with TBS-Tween-20 and incubated with the aforementioned secondary antibodies for 1 h at room temperature. Proteins were visualized using enhanced chemiluminescence reagents (Roche Diagnostics GmbH). Densitometric analysis was performed using ImageJ software (version 1.48; National Institutes of Health).

### Statistical analysis

GraphPad Prism 5 software (GraphPad Software, Inc.) was used to analyze the data. Data are presented as the mean ± standard deviation. All experiments were repeated 3 times. Two-tailed Student\'s t-test was used when two independent groups were compared, while one-way analysis of variance (ANOVA) followed by Tukey\'s multiple comparison was used for multiple comparison tests. A P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### NLK inhibits cell growth and migration

To examine whether overexpression of *NLK* affects cell growth, lentivirus transfection was used to upregulate the gene expression of *NLK* in A549 cells. From the western blot analysis, A549 cells showed stable overexpression of *NLK* compared with that in the control cells transfected with the vector only ([Fig. 1A](#f1-or-43-06-1845){ref-type="fig"}). Colony formation assay (CFA) demonstrated that overexpression of *NLK* significantly represses colony formation ability, and overexpression of *NLK* significantly repressed sphere formation capabilities (SFA) in the A549 cells ([Fig. 1B](#f1-or-43-06-1845){ref-type="fig"}). Wound healing assay was used to determine whether overexpression of *NLK* affected the migration ability of A549 cells, and it was found that overexpression of *NLK* resulted in significantly decreased migration of A549 cells compared with that in cells transfected with the vector only ([Fig. 1C](#f1-or-43-06-1845){ref-type="fig"}). The results suggest that *NLK* significantly inhibited cell growth and migration capabilities.

### NLK interacts with 14-3-3ζ

To further understand the mechanism of *NLK* in the regulation of cell growth and migration, IP and MS analyses were used to identify *NLK* binding proteins in A549 cells stably expressing C-terminally FLAG-tagged *NLK* (*NLK*-FLAG) created using lentivirus transfection. Cell extracts were subjected to IP with FLAG agarose beads. The specific bands of *NLK*-FLAG in isolated proteins were identified using western blot analysis ([Fig. 2A](#f2-or-43-06-1845){ref-type="fig"}). Subsequently, the isolated proteins, including *NLK*-FLAG and its associated proteins were analyzed using LC-MS/MS to identify *NLK*-interacting proteins. The tryptic peptides corresponding to 14-3-3ζ protein with a high sequence coverage were identified ([Fig. 2B](#f2-or-43-06-1845){ref-type="fig"}). The interaction between *NLK*-FLAG and 14-3-3ζ was further verified using western blot analysis with the precipitated proteins ([Fig. 2C](#f2-or-43-06-1845){ref-type="fig"}). Moreover, endogenous *NLK* and 14-3-3ζ also showed an interaction in A549 cells ([Fig. 2D](#f2-or-43-06-1845){ref-type="fig"}). These data indicate that 14-3-3ζ is a novel *NLK*-interacting protein.

### NLK inhibits the dimerization of 14-3-3ζ and restores 14-3-3ζ-repressed E-cadherin expression

A previous study has shown that 14-3-3ζ is responsible for silencing of E-cadherin during EMT ([@b15-or-43-06-1845]). Lentivirus transfection was used to upregulate the gene expression of 14-3-3ζ in A549 cells ([Fig. 3A](#f3-or-43-06-1845){ref-type="fig"}). It was subsequently confirmed that overexpression of 14-3-3ζ induced a more spindle-like cell shape and a scattered distribution, suggesting decreased epithelial cell-to-cell contacts in the A549 cells ([Fig. 3A](#f3-or-43-06-1845){ref-type="fig"}). In addition, A549 cells stably overexpressing 14-3-3ζ were transfected with the *NLK* lentivirus to create *NLK*/14-3-3ζ double-overexpressing cells. EMT morphological changes induced by 14-3-3ζ overexpression were inhibited by *NLK* overexpression ([Fig. 3A](#f3-or-43-06-1845){ref-type="fig"}). Subsequently it was confirmed that overexpression of 14-3-3ζ inhibited the expression of E-cadherin ([Fig. 3B](#f3-or-43-06-1845){ref-type="fig"}). Furthermore, *NLK*/14-3-3ζ double-overexpressing cells revealed restored expression of E-cadherin compared with that in cells overexpressing 14-3-3ζ ([Fig. 3B](#f3-or-43-06-1845){ref-type="fig"}). It has been reported that dimerization is essential for 14-3-3ζ stability and the ability of 14-3-3ζ to bind to its target proteins ([@b16-or-43-06-1845],[@b17-or-43-06-1845]). Using non-denaturing conditions, which would preserve any disulfide linkages during western blot analysis, an endogenous 14-3-3ζ dimer band was found in A549 cells ([Fig. 3C](#f3-or-43-06-1845){ref-type="fig"}). Moreover, the 14-3-3ζ monomer band and 14-3-3ζ dimer band were found to be increased in A549 cells stably overexpressing 14-3-3ζ. On the other hand, the 14-3-3ζ dimer band was inhibited in *NLK*/14-3-3ζ double-overexpressing cells as compared with that in 14-3-3ζ overexpressing cells ([Fig. 3C](#f3-or-43-06-1845){ref-type="fig"}).

At the protein level, expression of E-cadherin was evaluated in 8 human lung cancer cell lines using western blot analysis. There were no differences in the expression levels of 14-3-3ζ in these cells, and the expression levels between *NLK* and E-cadherin were highly correlated ([Fig. 3D](#f3-or-43-06-1845){ref-type="fig"}). These results suggest that *NLK* may be involved in 14-3-3ζ-regulated E-cadherin expression by the interaction with 14-3-3ζ. Using lentivirus transfection, A549 cells stably sole-expressing or co-expressing FLAG-14-3-3ζ and HA-14-3-3ζ were generated. As shown in [Fig. 4A](#f4-or-43-06-1845){ref-type="fig"}, FLAG-14-3-3ζ was co-immunoprecipitated with HA-14-3-3ζ in FLAG-14-3-3ζ and HA-14-3-3ζ co-expressing A549 cells. Notably, overexpression of untagged *NLK* in FLAG-14-3-3ζ and HA-14-3-3ζ co-expressing cells inhibited the interaction between FLAG-14-3-3ζ and HA-14-3-3ζ ([Fig. 4B and C](#f4-or-43-06-1845){ref-type="fig"}). These results suggest that *NLK* disturbs 14-3-3ζ-14-3-3ζ dimerization.

### NLK regulation of E-cadherin expression depends on the homodimer of 14-3-3ζ

Gly-rich linkers are flexible and naturally exist in a number of proteins of their Gly residues ([@b18-or-43-06-1845]--[@b20-or-43-06-1845]). Thus, Gly-rich linkers have been used to create fusion proteins with independent sequences, including the connection with the homodimer, ligand-receptor and co-activators ([@b21-or-43-06-1845]--[@b23-or-43-06-1845]). By fusing two copies of the 14-3-3ζ gene via a 10-amino acid Gly-rich linker, a non-dissociable dimer of 14-3-3ζ (14-3-3ζ-Fusion) with lentiviral vector ([Fig. 5A](#f5-or-43-06-1845){ref-type="fig"}) was generated. As shown in [Fig. 5A](#f5-or-43-06-1845){ref-type="fig"}, the expression of the fused dimer of 14-3-3ζ and endogenous 14-3-3ζ were examined using western blot analysis, under denaturing and non-denaturing conditions.

Moreover, spindle-like cell shape and a scattered distribution were also found in cells stably expressing 14-3-3ζ-Fusion. The EMT morphological changes were not inhibited by overexpression of *NLK* ([Fig. 5A](#f5-or-43-06-1845){ref-type="fig"}). Meanwhile, 14-3-3ζ-repressed E-cadherin expression could not be restored by *NLK* overexpression ([Fig. 5B](#f5-or-43-06-1845){ref-type="fig"}).

To further determine whether *NLK* binds to the monomer or dimer form of 14-3-3ζ, the endogenous interaction between *NLK* and 14-3-3ζ under non-denaturing conditions was investigated. As shown in [Fig. 5C](#f5-or-43-06-1845){ref-type="fig"}, *NLK* was found to be associated with the monomer form but not with the dimer form of 14-3-3ζ under non-denaturing conditions. Moreover, exogenous FLAG-tagged 14-3-3ζ dimer fusion protein (14-3-3ζ-Fusion-FLAG) could not bind to endogenous *NLK* in 14-3-3ζ-Fusion-FLAG expressing cells ([Fig. 5C](#f5-or-43-06-1845){ref-type="fig"}). In addition, wound healing assay revealed that 14-3-3ζ overexpression enhanced the migration of A549 cells. *NLK* was able to inhibit the increased migration from 14-3-3ζ overexpression. On the other hand, 14-3-3ζ-Fusion overexpression revealed a higher migration ability compared with that in 14-3-3ζ-overexpressing cells and this effect was not regulated by *NLK* ([Fig. 5D](#f5-or-43-06-1845){ref-type="fig"}). Together, these results suggest that *NLK* regulation of E-cadherin expression depends on the homodimer of 14-3-3ζ.

Discussion
==========

EMT is involved in cancer metastasis, migration, invasion, and progression. E-cadherin is essential for the maintenance of intercellular adhesion as a key component of the adherens junctions ([@b24-or-43-06-1845]). Thus, the loss of E-cadherin is considered to be a major hallmark of EMT and has been reported in various types of cancers ([@b25-or-43-06-1845]). 14-3-3ζ, a member of the evolutionally conserved family, mediates signal transduction by binding to phosphoserine-containing proteins. Dimerization is essential for 14-3-3ζ stability and the ability of 14-3-3ζ to bind its target proteins ([@b16-or-43-06-1845]). 14-3-3ζ was found to be responsible for silencing of E-cadherin during EMT ([@b15-or-43-06-1845]). In the present study, a novel *NLK*-interacting protein was identified. *NLK* was found to inhibit cell growth capabilities using colony formation assay. The number or size of spheres partly reveals the proliferation of cancer stem/progenitor cells ([@b26-or-43-06-1845]). The sphere formation assay revealed that *NLK* markedly repressed the sphere formation capacities in A549 cells, in the present study. Furthermore, wound healing assay was performed to examine the effect of *NL*K on migration ability. Overexpression of *NLK* markedly inhibited cell migration. As an *NLK*-interacting protein, 14-3-3ζ overexpressing cells revealed enhanced migration capacity. *NLK* and 14-3-3ζ co-expressing cells revealed decreased migration compared with that in cells only expressing 14-3-3ζ. These findings suggest that *NLK* inhibition of migration may be dependent on the regulation of 14-3-3ζ function.

14-3-3ζ has been previously found to promote EMT and inhibit the expression of E-cadherin ([@b15-or-43-06-1845]). In the present study, 14-3-3ζ was found to induce EMT and repress E-cadherin in A549 cells. Co-immunoprecipitation assay was performed with exogenous tagged protein or endogenous proteins to verify the interaction between *NLK* and 14-3-3ζ identified by LC-MS/MS analysis of *NLK*-interacting proteins. In light of the key role of *NLK* in the regulation of 14-3-3ζ-induced E-cadherin repression, A549 cells stably co-expressing FLAG-14-3-3ζ and HA-14-3-3ζ were constructed. FLAG-14-3-3ζ was found to be co-immunoprecipitated with HA-14-3-3ζ. Notably, overexpression of untagged *NLK* in FLAG-14-3-3ζ and HA-14-3-3ζ co-expressing cells inhibits the interaction between FLAG-14-3-3ζ and HA-14-3-3ζ. These results suggest that *NLK* disturbs the 14-3-3ζ-14-3-3ζ dimerization, and hence the function of *NLK* to regulate E-cadherin.

Gly-rich linkers naturally exist in a number of proteins and have been used to create fusion proteins with independent sequences, such as the connection with homodimer, ligand-receptor and co-activators ([@b18-or-43-06-1845]). Overexpression of 14-3-3ζ-Fusion created by Gly-rich linker successfully repressed the expression of E-cadherin, promoted EMT morphological changes and cell migration. Notably, *NLK* lost its ability to regulate the expression of E-cadherin, EMT morphological changes and cell migration induced by 14-3-3ζ-Fusion overexpression. In conclusion, the results from the present study reveals that *NLK* interacts with 14-3-3ζ to represses the expression of E-cadherin by interrupting 14-3-3ζ dimer formation.
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![*NLK* inhibits the cell growth and migration of A549 cells. (A) Western blot analysis of *NLK* protein expression in A549 cells transfected with the *NLK* lentivirus or vector lentivirus; Densitometric analysis of the relative expression level of *NLK*. \*P\<0.001 compared to the Vector group. (B) Colony formation assay (CFA): Representative images and quantification of the colony formation of A549 cells transfected with *NLK* or vector lentivirus. \*P\<0.01 compared to the Vector group. Sphere formation assay (SFA): The spheres were derived from A549 cells transfected with *NLK* lentivirus or vector lentivirus. \*\*P\<0.001 compared to the Vector group (scale bar, 200 µm). (C) Wound healing assay indicated that *NLK* overexpression suppressed A549 cell migration. \*P\<0.01 compared to the Vector group (scale bar, 200 µm). *NLK*, nemo-like kinase.](OR-43-06-1845-g00){#f1-or-43-06-1845}

![Association of *NLK* with 14-3-3ζ. (A) A549 cells expressing FLAG-tagged *NLK* were lysed and immunoprecipitation (IP) was performed by FLAG-M2 Affinity Gel. Immunoprecipitated protein was subjected to western blot and detected by FLAG antibody. (B) List of 14-3-3ζ peptides identified by LC-MS/MS. (C) Immunoprecipitated *NLK*-FLAG associated protein in A549 cells was subjected to western blot analysis by 14-3-3ζ antibody. (D) A549 cells were lysed and subjected to IP with *NLK* or 14-3-3ζ antibodies, controlled by corresponding IgG. Immunoprecipitated protein were then analyzed by western blot analysis. *NLK*, nemo-like kinase; LC-MS/MS, liquid chromatography with tandem mass spectrometry.](OR-43-06-1845-g01){#f2-or-43-06-1845}

![*NLK* regulates 14-3-3ζ-repressed E-cadherin expression. (A) Left panels: Expression of *NLK*, 14-3-3ζ and β-actin were detected by western blot in A549 cells transfected with the vector lentivirus, 14-3-3ζ lentivirus or 14-3-3ζ plus *NLK* lentivirus, and densitometric analysis of the relative expression levels of 14-3-3ζ and *NLK*. \*P\<0.001 compared to the Vector group; \*\*P\<0.001 compared to the other groups. Right images: The cells exhibited different morphologies. (B) Expression of E-cadherin and β-actin were detected by western blot analysis in A549 cells transfected with the vector lentivirus, 14-3-3ζ lentivirus or 14-3-3ζ plus *NLK* lentivirus, and densitometric analysis of the relative expression level of E-cadherin. \*P\<0.005 compared to other groups. (C) Under non-denaturing condition, the expression of 14-3-3ζ and β-actin were detected by western blot analysis in A549 cells transfected with the vector lentivirus, 14-3-3ζ lentivirus or 14-3-3ζ plus *NLK* lentivirus, and densitometric analysis of the relative expression levels of dimer and monomer of 14-3-3ζ. \*P\<0.01 compared to other groups; \*\*P\<0.05 compared to the Vector group. (D) Expression of *NLK*, E-cadherin, 14-3-3ζ and β-actin were detected by western blot analysis in 8 human lung cancer cell lines, and densitometric analysis of the relative expression levels of *NLK*, E-cadherin and 14-3-3ζ. \*P\<0.005 compared to the other groups. *NLK*, nemo-like kinase.](OR-43-06-1845-g02){#f3-or-43-06-1845}

![*NLK* inhibits the dimerization of 14-3-3ζ. (A) A549 cells stably sole-expressing or co-expressing FLAG-14-3-3ζ and HA-14-3-3ζ. Cell lysates was immunoprecipitated with HA Affinity Gel and subjected to western blot analysis as detected by the FLAG or HA antibody. (B) A549 cells co-expressing FLAG-14-3-3ζ and HA-14-3-3ζ were transfected with the vector lentivirus or untagged *NLK* lentivirus. Cell lysates was immunoprecipitated with HA Affinity Gel and subjected to western blot analysis. (C) Densitometric analysis of the relative expression level of untagged *NLK* and FLAG-tagged 14-3-3ζ associated with equal amounts of HA-tagged 14-3-3ζ. \*P\<0.001 compared to Vector group. *NLK*, nemo-like kinase.](OR-43-06-1845-g03){#f4-or-43-06-1845}

![The function of non-dissociable homodimer of 14-3-3ζ. (A) Two copies of the 14-3-3ζ gene via a 10-amino acid Gly-rich linker to get a non-dissociable dimer of 14-3-3ζ (14-3-3ζ-Fusion) with lentiviral vector. Expression of endogenous 14-3-3ζ and 14-3-3ζ-Fusion was detected by western blot analysis in A549 cells transfected with the vector and 14-3-3ζ-Fusion lentivirus (left: Under denaturing condition, right: Under non-denaturing condition). Densitometric analysis of the relative expression level of dimer and monomer of 14-3-3ζ. \*P\<0.005 compared to the Vector group. Lower images: The cells exhibited different morphologies with the transfection of the vector, 14-3-3ζ-Fusion or 14-3-3ζ-Fusion plus untagged *NLK* lentivirus (scale bar, 100 µm). (B) Expression of E-cadherin and β-actin was detected by western blot analysis in A549 cells transfected with the vector lentivirus, 14-3-3ζ-Fusion or 14-3-3ζ-Fusion plus untagged *NLK* lentivirus. Densitometric analysis of the relative expression level of E-cadherin. \*P\<0.001 compared to the Vector group. (C) Left: A549 cells were lysed and subjected to IP with *NLK* antibodies, controlled by corresponding IgG. Immunoprecipitated protein were then analyzed by western blot analysis under non-denaturing condition. Right: Immunoprecipitated 14-3-3ζ-Fusion-FLAG-associated protein in A549 cells was subjected to western blot analysis. (D) Wound healing analysis of A549 cells transfected with the vector, 14-3-3ζ, 14-3-3ζ-Fusion, 14-3-3ζ plus *NLK* or 14-3-3ζ-Fusion plus *NLK* lentivirus. \*P\<0.005 compared to the Vector or 14-3-3ζ+*NLK* groups (scale bar, 200 µm). *NLK*, nemo-like kinase; IP, immunoprecipitation.](OR-43-06-1845-g04){#f5-or-43-06-1845}
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